City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border 		  
  PROFILE 
The following is a list of available studies directed by  Amrita Y. Krishnan, MD  
Search results:  2  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 07076
   P.I.: Amrita Krishnan, MD
Title: A Phase II Study of Yttrium-90-Labeled Anti-CD20 Monoclonal Antibody in Combination with High-Dose Beam (BCNU, Etoposide, Cytarabine and Melphalan) Followed by Autologous Stem Cell Transplantation for Patients with Poor Risk/Relapsed B-Cell Lymphoma
 
Click here for  Full Eligibility Criteria
 99067
   P.I.: Amrita Krishnan, MD
Title: High Dose Chemotherapy and Combination anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma
 
Click here for  Full Eligibility Criteria
 

  
© 2009 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.